Douglas Maneval

Douglas Maneval has extensive work experience in the pharmaceutical industry, particularly in roles related to quality assurance and compliance. Douglas currently holds the position of Executive Director R&D Quality at Intercept Pharmaceuticals since 2021. Prior to that, they worked at AbbVie from 2020 to 2020 as the Executive Director Pharmacovigilance Quality Assurance. At AbbVie, they oversaw and directed the global audit program for clinical development and pharmacovigilance activities. Maneval also has experience at Allergan, where they served as the Executive Director -Pharmacovigilance Quality / Clinical Quality from 2011 to 2020. Douglas'sresponsibilities in this role included managing the global audit program and facilitating regulatory inspections. Before Allergan, Maneval worked at Merck as the Head of Global Pharmacovigilance Compliance from 2009 to 2011. Douglas also worked at Schering Pharmaceuticals as the Director PV Corporate Audit from 2007 to 2009 and at Johnson & Johnson in various roles related to pharmacovigilance quality assurance and auditing from 1990 to 2007. Throughout their career, Maneval has demonstrated strong leadership skills and expertise in managing audit programs and ensuring compliance with regulatory standards.

Douglas Maneval holds a BS degree in Biology from the University of Pittsburgh. However, the specific start and end years of their education at this institution are not provided.